ValoreQ4, 24Q1, 25Q2, 25TTMFlussi di cassa derivanti dalle attività di investimento3.03 M3.85 M2.66 M5.3 MLiquidità derivante dalle attività di finanziamento-435 K-40 K——Liquidità libera-5.94 M-5.54 M-5.65 M-22.01 M
Pluri Inc
Pluri Inc., formerly Pluristem Therapeutics, is an Israeli company engaged in the development of human placental adherent stromal cells for commercial use in disease treatment. According to the company's website, it extracts adult stem cells exclusively from postnatal placentas.